Risk-Characterization Framework for Decision-Making at the Food and Drug Administration

Loading edition detail...

Preparing this view.

Risk-Characterization Framework for Decision-Making at the Food and Drug Administration

Phase II Committee on Ranking FDA Product Categories Based on Health Consequences, Board on Environmental Studies and Toxicology, Institute of Medicine, Division on Earth and Life Studies, National Research Council

Bookitis Pick

Risk-Characterization Framework for Decision-Making at the Foo...Phase II Committee on Ranking FDA Product Categories Based on Health Consequences, Board on Environmental Studies and Toxicology, Institute of Medicine, Division on Earth and Life Studies, National Research Council

This page shows the publication-specific record: publisher, date, identifiers, and all of the context needed to decide whether this is the copy you want.

Main catalog entry More like this

Publisher	National Academies Press
Search language	english
ISBN_13	978-0-309-21284-7 primary

Other editions of this title

Publication-specific alternatives linked to the same work.